Rebimastat Completed Phase 2 Trials for Adenocarcinoma of Prostate / Recurrent Prostate Cancer / Stage IV Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00039104Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer